Wednesday, October 28, 2009

Are You Still Considering the Flu Vaccine?

Many doctors, researchers and infectious disease experts admit the flu vaccine is just about worthless. Here are just a few:

There is no evidence that any influenza vaccine thus far developed is effective in preventing or mitigating any attack of influenza…The producers of these vaccines know they are worthless, but they go on selling them anyway.

- Dr. Anthony Morris, distinguished virologist and former Chief Vaccine Officer at the U.S. Federal Drug Administration (FDA)

I have never been impressed with its efficacy.

- Dr. Graeme Laver, PhD, original co-inventor of the flu vaccine

The truth is we move annually into periods where there are dramatic increases in flu-like causing pathogens, however, the majority of these are unrelated to any strain of influenza virus. There can between 150 and 200 different infectious pathogens that produce flu-like symptoms during a typical ‘flu season.’ This is true during every flu season and this year is no different...all flu vaccinations, including the swine flu, are useless for protecting people from these many prevalent infectious organisms.

- Dr. Gary Null, Ph.D, NY Times bestselling author; former lead investigator for ABC Radio Network's "Caveat Emptor"

An influenza vaccine is not working for the majority of influenza-like illnesses because it is only designed to combat influenza viruses. For that reason, the vaccine changes nothing when it comes to the heightened mortality rate during the winter months.

- Dr. Tom Jefferson, head of vaccine studies at international Cochrane Database Collaboration

Last week, Switzerland’s health authorities rejected Novartis’ new swine flu vaccine, Celtura, being targeted for women and children, because the company’s studies were insufficient to guarantee its safety. In addition, the new Novartis vaccine, which uses a cell base from dogs, was found to be contaminated with canine-specific bacteria…This is the same Novartis whose Fluvirin H1N1 vaccine being distributed in the US relied only on a hasty clinical efficacy and safety trial enrolling only a small number of health adults. Novartis likely remains unperturbed. The Swiss pharmaceutical giant has reported a $6.1 billion profit so far this year and expects to boost sales for the final quarter with is swine flu vaccine.

- Richard Gale, former Senior Research Analyst in the biotechnology and genomic industries

Helpful Links:

The Authorative Guide to Vaccine Legal Exemptions

Colloidal Silver Kills Viruses

Colloidal Silver Cures MRSA

The Immune Manual

Make your own colloidal silver

The Colloidal Silver Secrets Video

The Ultimate Colloidal Silver Manual

The New Micro-Particle Colloidal Silver Generator

Colloidal Silver Secrets blog

Secrets of Natural Healing blog

No comments:

Post a Comment